Organoids and Spheroids Market Size, Trends, Analysis, and Outlook Organoids By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Others), Organoids By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), Spheroids By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Spheroids By Source (Cell Line, Primary Cell, iPSCs Derived Cells), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing), By End-user (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic centers), by Region, Country, Segment, and Companies, 2024-2030
The global Organoids and Spheroids market size is poised to register 21.05% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Organoids and Spheroids market across Organoids By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Others), Organoids By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), Spheroids By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Spheroids By Source (Cell Line, Primary Cell, iPSCs Derived Cells), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing), By End-user (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic centers).
The Organoids and Spheroids Market is experiencing growth driven by the increasing adoption of three-dimensional (3D) cell culture models and organotypic cultures in drug discovery, toxicology testing, and regenerative medicine research, and the advancements in tissue engineering, stem cell technology, and biomaterials for the development of complex multicellular structures resembling native tissues and organs. Organoids and spheroids are self-assembled 3D cell aggregates derived from stem cells, primary cells, or cell lines that recapitulate the structural and functional properties of specific tissues or organs in vitro, allowing researchers to study organ development, disease pathogenesis, and drug response in physiologically relevant models. Key trends shaping its future include the development of organoid and spheroid culture protocols for various tissue types and disease models, the customization of organoid and spheroid platforms with microfluidic devices and bioreactors for perfusion culture and long-term maintenance, and the integration of organoid and spheroid models with high-content imaging and omics technologies for multi-dimensional analysis of cellular phenotypes and molecular signatures. Moreover, factors such as the increasing demand for predictive preclinical models and personalized medicine approaches, the advancements in genome editing and gene editing technologies for disease modeling and drug target validation, and the regulatory initiatives to promote the use of alternative methods and 3D cell culture models in drug safety and efficacy assessment are expected to drive market growth in 2024 and beyond.
Organoids and Spheroids Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Organoids and Spheroids market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Organoids and Spheroids survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Organoids and Spheroids industry.
Key market trends defining the global Organoids and Spheroids demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Organoids and Spheroids Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Organoids and Spheroids industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Organoids and Spheroids companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Organoids and Spheroids industry
Leading Organoids and Spheroids companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Organoids and Spheroids companies.
Organoids and Spheroids Market Study- Strategic Analysis Review
The Organoids and Spheroids market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Organoids and Spheroids industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Organoids and Spheroids Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Organoids and Spheroids Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Organoids and Spheroids market segments. Similarly, Strong end-user demand is encouraging Canadian Organoids and Spheroids companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Organoids and Spheroids market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Organoids and Spheroids Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Organoids and Spheroids industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Organoids and Spheroids market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Organoids and Spheroids Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Organoids and Spheroids in Asia Pacific. In particular, China, India, and South East Asian Organoids and Spheroids markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Organoids and Spheroids Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Organoids and Spheroids Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Organoids and Spheroids market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Organoids and Spheroids.
Organoids and Spheroids Market Company Profiles
The global Organoids and Spheroids market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are 3D Biomatrix, 3D Biotek LLC, AMS Biotechnology Ltd, ATCC, Cellesce Ltd, Corning Inc, Greiner Bio-One, HubrechtOrganoid Technology, InSphero/Perkin Elmer, Kuraray, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc, Thermo Fisher Scientific Inc
Recent Organoids and Spheroids Market Developments
The global Organoids and Spheroids market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Organoids and Spheroids Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
Organoids By Type
Neural Organoids
Hepatic Organoids
Intestinal Organoids
Others
Organoids By Method
General Submerged Method for Organoid Culture
Crypt Organoid Culture Techniques
Air Liquid Interface (ALI) Method for Organoid Culture
Clonal Organoids from Lgr5+ Cells
Brain and Retina Organoid Formation Protocol
Organoids By Source
Primary Tissues
Stem Cells
Spheroids By Type
Multicellular tumor spheroids (MCTS)
Neurospheres
Mammospheres
Hepatospheres
Embryoid bodies
Spheroids By Method
Micropatterned Plates
Low Cell Attachment Plates
Hanging Drop Method
Others
Spheroids By Source
Cell Line
Primary Cell
iPSCs Derived Cells
By Application
Developmental Biology
Personalized Medicine
Regenerative Medicine
Disease Pathology Studies
Drug Toxicity & Efficacy Testing
By End-user
Biotechnology and pharmaceutical industries
Academic & Research Institutes
Hospitals and diagnostic centers
Geographical Segmentation:
3D Biomatrix
3D Biotek LLC
AMS Biotechnology Ltd
ATCC
Cellesce Ltd
Corning Inc
Greiner Bio-One
HubrechtOrganoid Technology
InSphero/Perkin Elmer
Kuraray
Lonza
Merck KGaA
Prellis Biologics
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
The Organoids and Spheroids Market is experiencing growth driven by the increasing adoption of three-dimensional (3D) cell culture models and organotypic cultures in drug discovery, toxicology testing, and regenerative medicine research, and the advancements in tissue engineering, stem cell technology, and biomaterials for the development of complex multicellular structures resembling native tissues and organs. Organoids and spheroids are self-assembled 3D cell aggregates derived from stem cells, primary cells, or cell lines that recapitulate the structural and functional properties of specific tissues or organs in vitro, allowing researchers to study organ development, disease pathogenesis, and drug response in physiologically relevant models. Key trends shaping its future include the development of organoid and spheroid culture protocols for various tissue types and disease models, the customization of organoid and spheroid platforms with microfluidic devices and bioreactors for perfusion culture and long-term maintenance, and the integration of organoid and spheroid models with high-content imaging and omics technologies for multi-dimensional analysis of cellular phenotypes and molecular signatures. Moreover, factors such as the increasing demand for predictive preclinical models and personalized medicine approaches, the advancements in genome editing and gene editing technologies for disease modeling and drug target validation, and the regulatory initiatives to promote the use of alternative methods and 3D cell culture models in drug safety and efficacy assessment are expected to drive market growth in 2024 and beyond.
Organoids and Spheroids Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Organoids and Spheroids market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Organoids and Spheroids survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Organoids and Spheroids industry.
Key market trends defining the global Organoids and Spheroids demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Organoids and Spheroids Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Organoids and Spheroids industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Organoids and Spheroids companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Organoids and Spheroids industry
Leading Organoids and Spheroids companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Organoids and Spheroids companies.
Organoids and Spheroids Market Study- Strategic Analysis Review
The Organoids and Spheroids market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Organoids and Spheroids industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Organoids and Spheroids Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Organoids and Spheroids Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Organoids and Spheroids market segments. Similarly, Strong end-user demand is encouraging Canadian Organoids and Spheroids companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Organoids and Spheroids market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Organoids and Spheroids Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Organoids and Spheroids industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Organoids and Spheroids market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Organoids and Spheroids Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Organoids and Spheroids in Asia Pacific. In particular, China, India, and South East Asian Organoids and Spheroids markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Organoids and Spheroids Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Organoids and Spheroids Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Organoids and Spheroids market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Organoids and Spheroids.
Organoids and Spheroids Market Company Profiles
The global Organoids and Spheroids market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are 3D Biomatrix, 3D Biotek LLC, AMS Biotechnology Ltd, ATCC, Cellesce Ltd, Corning Inc, Greiner Bio-One, HubrechtOrganoid Technology, InSphero/Perkin Elmer, Kuraray, Lonza, Merck KGaA, Prellis Biologics, STEMCELL Technologies Inc, Thermo Fisher Scientific Inc
Recent Organoids and Spheroids Market Developments
The global Organoids and Spheroids market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Organoids and Spheroids Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
Organoids By Type
Neural Organoids
Hepatic Organoids
Intestinal Organoids
Others
Organoids By Method
General Submerged Method for Organoid Culture
Crypt Organoid Culture Techniques
Air Liquid Interface (ALI) Method for Organoid Culture
Clonal Organoids from Lgr5+ Cells
Brain and Retina Organoid Formation Protocol
Organoids By Source
Primary Tissues
Stem Cells
Spheroids By Type
Multicellular tumor spheroids (MCTS)
Neurospheres
Mammospheres
Hepatospheres
Embryoid bodies
Spheroids By Method
Micropatterned Plates
Low Cell Attachment Plates
Hanging Drop Method
Others
Spheroids By Source
Cell Line
Primary Cell
iPSCs Derived Cells
By Application
Developmental Biology
Personalized Medicine
Regenerative Medicine
Disease Pathology Studies
Drug Toxicity & Efficacy Testing
By End-user
Biotechnology and pharmaceutical industries
Academic & Research Institutes
Hospitals and diagnostic centers
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
3D Biomatrix
3D Biotek LLC
AMS Biotechnology Ltd
ATCC
Cellesce Ltd
Corning Inc
Greiner Bio-One
HubrechtOrganoid Technology
InSphero/Perkin Elmer
Kuraray
Lonza
Merck KGaA
Prellis Biologics
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Organoids and Spheroids Market Overview and Key Findings, 2024
1.2 Organoids and Spheroids Market Size and Growth Outlook, 2021- 2030
1.3 Organoids and Spheroids Market Growth Opportunities to 2030
1.4 Key Organoids and Spheroids Market Trends and Challenges
1.4.1 Organoids and Spheroids Market Drivers and Trends
1.4.2 Organoids and Spheroids Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Organoids and Spheroids Companies
2. ORGANOIDS AND SPHEROIDS MARKET SIZE OUTLOOK TO 2030
2.1 Organoids and Spheroids Market Size Outlook, USD Million, 2021- 2030
2.2 Organoids and Spheroids Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ORGANOIDS AND SPHEROIDS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ORGANOIDS AND SPHEROIDS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
Organoids By Type
Neural Organoids
Hepatic Organoids
Intestinal Organoids
Others
Organoids By Method
General Submerged Method for Organoid Culture
Crypt Organoid Culture Techniques
Air Liquid Interface (ALI) Method for Organoid Culture
Clonal Organoids from Lgr5+ Cells
Brain and Retina Organoid Formation Protocol
Organoids By Source
Primary Tissues
Stem Cells
Spheroids By Type
Multicellular tumor spheroids (MCTS)
Neurospheres
Mammospheres
Hepatospheres
Embryoid bodies
Spheroids By Method
Micropatterned Plates
Low Cell Attachment Plates
Hanging Drop Method
Others
Spheroids By Source
Cell Line
Primary Cell
iPSCs Derived Cells
By Application
Developmental Biology
Personalized Medicine
Regenerative Medicine
Disease Pathology Studies
Drug Toxicity & Efficacy Testing
By End-user
Biotechnology and pharmaceutical industries
Academic & Research Institutes
Hospitals and diagnostic centers
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Organoids and Spheroids Market, 2025
5.2 Asia Pacific Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Organoids and Spheroids Market, 2025
5.5 Europe Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.6 Europe Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Organoids and Spheroids Market, 2025
5.8 North America Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.9 North America Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Organoids and Spheroids Market, 2025
5.11 South America Pacific Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.12 South America Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Organoids and Spheroids Market, 2025
5.14 Middle East Africa Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Organoids and Spheroids Market Size Outlook and Revenue Growth Forecasts
6.2 US Organoids and Spheroids Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Organoids and Spheroids Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Organoids and Spheroids Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Organoids and Spheroids Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Organoids and Spheroids Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Organoids and Spheroids Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Organoids and Spheroids Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Organoids and Spheroids Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Organoids and Spheroids Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Organoids and Spheroids Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Organoids and Spheroids Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Organoids and Spheroids Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Organoids and Spheroids Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Organoids and Spheroids Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Organoids and Spheroids Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Organoids and Spheroids Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Organoids and Spheroids Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Organoids and Spheroids Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Organoids and Spheroids Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Organoids and Spheroids Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Organoids and Spheroids Industry Drivers and Opportunities
7. ORGANOIDS AND SPHEROIDS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ORGANOIDS AND SPHEROIDS COMPANY PROFILES
8.1 Profiles of Leading Organoids and Spheroids Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
3D BIOMATRIX
3D BIOTEK LLC
AMS Biotechnology Ltd
ATCC
Cellesce Ltd
Corning Inc
Greiner Bio-One
HubrechtOrganoid Technology
InSphero/Perkin Elmer
Kuraray
Lonza
Merck KGaA
Prellis Biologics
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Organoids and Spheroids Market Overview and Key Findings, 2024
1.2 Organoids and Spheroids Market Size and Growth Outlook, 2021- 2030
1.3 Organoids and Spheroids Market Growth Opportunities to 2030
1.4 Key Organoids and Spheroids Market Trends and Challenges
1.4.1 Organoids and Spheroids Market Drivers and Trends
1.4.2 Organoids and Spheroids Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Organoids and Spheroids Companies
2. ORGANOIDS AND SPHEROIDS MARKET SIZE OUTLOOK TO 2030
2.1 Organoids and Spheroids Market Size Outlook, USD Million, 2021- 2030
2.2 Organoids and Spheroids Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ORGANOIDS AND SPHEROIDS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ORGANOIDS AND SPHEROIDS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
Organoids By Type
Neural Organoids
Hepatic Organoids
Intestinal Organoids
Others
Organoids By Method
General Submerged Method for Organoid Culture
Crypt Organoid Culture Techniques
Air Liquid Interface (ALI) Method for Organoid Culture
Clonal Organoids from Lgr5+ Cells
Brain and Retina Organoid Formation Protocol
Organoids By Source
Primary Tissues
Stem Cells
Spheroids By Type
Multicellular tumor spheroids (MCTS)
Neurospheres
Mammospheres
Hepatospheres
Embryoid bodies
Spheroids By Method
Micropatterned Plates
Low Cell Attachment Plates
Hanging Drop Method
Others
Spheroids By Source
Cell Line
Primary Cell
iPSCs Derived Cells
By Application
Developmental Biology
Personalized Medicine
Regenerative Medicine
Disease Pathology Studies
Drug Toxicity & Efficacy Testing
By End-user
Biotechnology and pharmaceutical industries
Academic & Research Institutes
Hospitals and diagnostic centers
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Organoids and Spheroids Market, 2025
5.2 Asia Pacific Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Organoids and Spheroids Market, 2025
5.5 Europe Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.6 Europe Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Organoids and Spheroids Market, 2025
5.8 North America Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.9 North America Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Organoids and Spheroids Market, 2025
5.11 South America Pacific Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.12 South America Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Organoids and Spheroids Market, 2025
5.14 Middle East Africa Organoids and Spheroids Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Organoids and Spheroids Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Organoids and Spheroids Market Size Outlook and Revenue Growth Forecasts
6.2 US Organoids and Spheroids Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Organoids and Spheroids Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Organoids and Spheroids Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Organoids and Spheroids Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Organoids and Spheroids Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Organoids and Spheroids Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Organoids and Spheroids Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Organoids and Spheroids Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Organoids and Spheroids Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Organoids and Spheroids Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Organoids and Spheroids Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Organoids and Spheroids Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Organoids and Spheroids Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Organoids and Spheroids Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Organoids and Spheroids Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Organoids and Spheroids Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Organoids and Spheroids Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Organoids and Spheroids Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Organoids and Spheroids Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Organoids and Spheroids Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Organoids and Spheroids Industry Drivers and Opportunities
7. ORGANOIDS AND SPHEROIDS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ORGANOIDS AND SPHEROIDS COMPANY PROFILES
8.1 Profiles of Leading Organoids and Spheroids Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
3D BIOMATRIX
3D BIOTEK LLC
AMS Biotechnology Ltd
ATCC
Cellesce Ltd
Corning Inc
Greiner Bio-One
HubrechtOrganoid Technology
InSphero/Perkin Elmer
Kuraray
Lonza
Merck KGaA
Prellis Biologics
STEMCELL Technologies Inc
Thermo Fisher Scientific Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
